Oxandrolone
Anavar. Mild 17α-alkylated DHT derivative. Popular for cutting cycles with relatively low liver stress compared to other orals.
Overview
Anavar. Mild 17α-alkylated DHT derivative. Popular for cutting cycles with relatively low liver stress compared to other orals.
Significantly lowers SHBG, mild liver stress (17-alpha alkylated but less hepatotoxic than others), worsens lipids (especially HDL suppression), can elevate LDL
Compound Guide
Ester: None -- oral 17-alpha alkylated compound. No ester; absorbed directly via GI tract.
Dosage:
- Enhancement (male): 40-80 mg/day for 6-8 weeks
- Split dose 2x/day (morning + evening) due to short half-life
Administration:
- Oral only -- no injection required
- Take with meals to reduce GI upset
Key Notes:
- Mildest oral AAS -- lowest hepatotoxicity of the 17-alpha alkylated compounds
- Despite mild reputation, still significantly suppresses HDL and can raise LDL
- Dramatically lowers SHBG -- can increase free testosterone disproportionately
- Very short detection time (3 weeks) vs other AAS
- Popular as a "finisher" in the last 6-8 weeks of a cycle
- Does not aromatise -- no direct E2 increase
- Run with a testosterone base (still suppresses natural production)
- Liver support (NAC, TUDCA) recommended even though hepatotoxicity is mild
Usage History
Marker Interactions
Frequently Asked Questions
Related Articles
Does Your DNA Decide How You Metabolize Steroids and Meds?
Use your 23andMe raw data to read how you metabolize steroids, tamoxifen, statins and GLP-1 drugs. Free, in-browser, nothing uploaded.
How Much Muscle You Lose Cutting on Retatrutide
TRIUMPH-1 showed 28.3% weight loss. Here's how much was muscle, what DEXA data predicts for athletes, and how to preserve muscle on a retatrutide cut.
Bloodwork Every Woman on Anavar Should Run in 2026
Female-specific anavar bloodwork guide. Dose-response data 5 to 20 mg, HDL crash, virilization markers, menstrual disruption, stop-thresholds, reversibility.
Retatrutide Bloodwork: The Triple Agonist Monitoring Guide
What to test on retatrutide. Monitoring protocol for the GLP-1/GIP/glucagon triple agonist: liver, thyroid, pancreas, glucose, and muscle markers.
Quick Reference
Category
AAS
Half-Life
8-10 hours
Detection Time
3 weeks